Moreover, the phenotype variable penetrance is a well established finding in humans with FSGS related to TRPC6 mutations, suggesting that it may contribute to glomerular diseases in a multi-hit setting [30]. This evidence concerns the gene TRPC6 and focal segmental glomerulosclerosis.